
BIO-Europe 2025
Look for us at BIO Europe, driving innovation and shaping the future of clinical research. Visit us at booth #C178.
Look for us at BIO Europe, driving innovation and shaping the future of clinical research. Visit us at booth #C178.
BIO-Europe Fall is Europe’s premier biopharma partnering conference, bringing together biotech, pharma, and investment leaders from around the globe for strategic networking and collaboration. The program features inspiring keynotes, interactive panels, and targeted workshops, while the exhibit floor highlights cutting-edge technologies and services. Citeline is proud to be part of this important industry event.
Visit us at booth #C178
Learn more and register for the event by visiting the event website.
An incisive, data-led dialogue between an industry analyst and journalist exploring Europe’s current innovation strengths, gaps, and global positioning in life sciences. This session sets the stage for a broader reflection on whether Europe is collaborating in harmony or charting a solo course in the biopharma innovation symphony.
As global biopharma enters a new era defined by rapid scientific advances, emerging markets, and shifting commercial models, the question looms: can Europe generate the innovation required to stay in the game? In this timely session, two CEOs will offer their perspectives on Europe’s position in the global innovation hierarchy. They will examine the structural strength and critical gaps within the region’s R&D ecosystem, from translational science to venture capital and commercialization pathways. With China investing heavily in next-gen biotech, threatening the US’s lead in scale and investment, and industry paradigms being rewritten, this conversation will tackle the tough question: what must Europe do now to ensure it remains not just relevant, but indispensable, to the future of global healthcare innovation?
Daniel Chancellor
VP of Thought Leadership, Norstella
Daniel has more than 15 years of experience in the biopharma industry, spanning roles in drug discovery, market analysis, competitive intelligence, and strategic consulting. Beginning his advisory career at Citeline, Daniel now oversees the thought leadership program for Norstella and its constituent companies, producing materials that support clients across a range of hot topics in the biopharma industry. As part of this, Daniel regularly participates in webinars, conferences, and other speaking arrangements, and he has provided expert insights across a wide range of leading industry and business publications. Prior to joining Citeline, Daniel worked as a medicinal chemist at the UK biotech company Summit Therapeutics and graduated with First Class Honors in Natural Sciences from the University of Bath.